| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidence
|
Ke, E-E
|
|
2016
|
|
3 |
p. 256-264
|
artikel
|
| 2 |
Ambrisentan therapy in pulmonary hypertension: clinical use and tolerability in a referral centre
|
Condliffe, Robin
|
|
2014
|
|
3 |
p. 71-77
|
artikel
|
| 3 |
A new horizon in the treatment of biofilm-associated tonsillitis
|
Ciftci, Zafer
|
|
2014
|
|
3 |
p. 78-83
|
artikel
|
| 4 |
Antifungal medication is efficient in the treatment of sarcoidosis
|
Terčelj, Marjeta
|
|
2011
|
|
3 |
p. 157-162
|
artikel
|
| 5 |
Bodily isomerism is an independent risk factor for pulmonary hypertension in adults with congenital heart disease
|
Loomba, Rohit S.
|
|
2016
|
|
3 |
p. 194-199
|
artikel
|
| 6 |
Can immunogenetics illuminate the diverse manifestations of respiratory infections?
|
Affandi, Jacquita S.
|
|
2010
|
|
3 |
p. 161-176
|
artikel
|
| 7 |
COPD: a multifactorial systemic disease
|
Huertas, Alice
|
|
2011
|
|
3 |
p. 217-224
|
artikel
|
| 8 |
Corrigendum
|
|
|
2016
|
|
3 |
p. 289
|
artikel
|
| 9 |
Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting
|
Miravitlles, Marc
|
|
2013
|
|
3 |
p. 139-150
|
artikel
|
| 10 |
Early life influences on the development of chronic obstructive pulmonary disease
|
Stocks, Janet
|
|
2013
|
|
3 |
p. 161-173
|
artikel
|
| 11 |
Editorial: Unifying the genetics, co-morbidities and management of COPD
|
Wood, Alice M.
|
|
2008
|
|
3 |
p. 113-117
|
artikel
|
| 12 |
Efficacy of tiotropium in the prevention of exacerbations of COPD
|
Anzueto, Antonio
|
|
2009
|
|
3 |
p. 103-111
|
artikel
|
| 13 |
Emerging therapies in cystic fibrosis
|
Anderson, Paula
|
|
2010
|
|
3 |
p. 177-185
|
artikel
|
| 14 |
Inhaled corticosteroids and the increased risk of pneumonia: what’s new? A 2015 updated review
|
Iannella, Hernan
|
|
2016
|
|
3 |
p. 235-255
|
artikel
|
| 15 |
Limiting volume with modern ventilators
|
Wing, Thomas J.
|
|
2015
|
|
3 |
p. 75-83
|
artikel
|
| 16 |
Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease
|
Jones, Paul W.
|
|
2015
|
|
3 |
p. 84-96
|
artikel
|
| 17 |
Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease
|
Qiu, Shilin
|
|
2017
|
|
3 |
p. 147-155
|
artikel
|
| 18 |
Malignant pleural mesothelioma: an update on diagnosis and treatment options
|
Kondola, Sanjana
|
|
2016
|
|
3 |
p. 275-288
|
artikel
|
| 19 |
Management of allergic bronchopulmonary aspergillosis: a review and update
|
Mahdavinia, Mahboobeh
|
|
2012
|
|
3 |
p. 173-187
|
artikel
|
| 20 |
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease
|
Sadowska, Anna M.
|
|
2012
|
|
3 |
p. 127-135
|
artikel
|
| 21 |
Nasal obstruction as a drug side effect
|
Cingi, Cemal
|
|
2011
|
|
3 |
p. 175-182
|
artikel
|
| 22 |
Nintedanib in the treatment of idiopathic pulmonary fibrosis
|
Mazzei, Mariano E.
|
|
2015
|
|
3 |
p. 121-129
|
artikel
|
| 23 |
Novel approaches to the management of noneosinophilic asthma
|
Thomson, Neil C.
|
|
2016
|
|
3 |
p. 211-234
|
artikel
|
| 24 |
NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease
|
Vogelmeier, Claus
|
|
2011
|
|
3 |
p. 163-173
|
artikel
|
| 25 |
Optimizing quality of life in patients with idiopathic pulmonary fibrosis
|
van Manen, Mirjam J. G.
|
|
2017
|
|
3 |
p. 157-169
|
artikel
|
| 26 |
Original Research: Role of phosphodiesterases in modulation of BKCa channels in hypertensive pulmonary arterial smooth muscle
|
Shu Zhu,
|
|
2008
|
|
3 |
p. 119-127
|
artikel
|
| 27 |
PPARγ as a potential therapeutic target in pulmonary hypertension
|
Sutliff, Roy L.
|
|
2010
|
|
3 |
p. 143-160
|
artikel
|
| 28 |
Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice
|
Llor, Carl
|
|
2013
|
|
3 |
p. 131-137
|
artikel
|
| 29 |
Prophylactic antibiotic therapy in chronic obstructive pulmonary disease
|
Maraffi, Tommaso
|
|
2010
|
|
3 |
p. 135-142
|
artikel
|
| 30 |
Pulmonary hypertension complicated by pericardial effusion: a single center experience
|
Honeycutt, Gregory R.
|
|
2013
|
|
3 |
p. 151-159
|
artikel
|
| 31 |
Reactive oxygen species as therapeutic targets in pulmonary hypertension
|
Freund-Michel, Véronique
|
|
2013
|
|
3 |
p. 175-200
|
artikel
|
| 32 |
Respiratory failure, lung infiltrates, and hemoptysis in a woman with chronic isopropyl alcohol inhalation
|
Blow, Benjamin J.
|
|
2012
|
|
3 |
p. 189-193
|
artikel
|
| 33 |
Review: Airway smooth muscle as a model for new investigative drugs in asthma
|
Baroffio, Michele
|
|
2008
|
|
3 |
p. 129-139
|
artikel
|
| 34 |
Review: Control of asthma
|
Zervas, Eleftherios
|
|
2008
|
|
3 |
p. 141-148
|
artikel
|
| 35 |
Review: Evaluating combination therapies for asthma: pros, cons, and comparative benefits
|
Bjermer, Leif
|
|
2008
|
|
3 |
p. 149-161
|
artikel
|
| 36 |
Review: Stem cell therapy: the great promise in lung disease
|
Siniscalco, Dario
|
|
2008
|
|
3 |
p. 173-177
|
artikel
|
| 37 |
Review: Therapeutic perspectives in bronchial vascular remodeling in COPD
|
Zanini, Andrea
|
|
2008
|
|
3 |
p. 179-187
|
artikel
|
| 38 |
Review: Tissue remodeling and angiogenesis in asthma: the role of the eosinophil
|
Nissim Ben Efraim, A.H.
|
|
2008
|
|
3 |
p. 163-171
|
artikel
|
| 39 |
Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis
|
Abdel-Rahman, Omar
|
|
2016
|
|
3 |
p. 183-193
|
artikel
|
| 40 |
Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists?
|
Pitsiou, Georgia G.
|
|
2009
|
|
3 |
p. 99-101
|
artikel
|
| 41 |
Sex-specific cardiopulmonary exercise testing indices related to hemodynamics in idiopathic pulmonary arterial hypertension
|
Yuan, Ping
|
|
2017
|
|
3 |
p. 135-145
|
artikel
|
| 42 |
Sneeze reflex: facts and fiction
|
Songu, Murat
|
|
2009
|
|
3 |
p. 131-141
|
artikel
|
| 43 |
Storage in ultra-low-temperature decreases the levels of IgM anticardiolipin antibody in serum samples from tuberculosis patients
|
Ng, Alexandra
|
|
2014
|
|
3 |
p. 93-95
|
artikel
|
| 44 |
Targeted approaches to the treatment of pulmonary hypertension
|
Fares, Wassim H.
|
|
2012
|
|
3 |
p. 147-159
|
artikel
|
| 45 |
Targeting the immune system to treat lung cancer: rationale and clinical experience
|
Guibert, Nicolas
|
|
2015
|
|
3 |
p. 105-120
|
artikel
|
| 46 |
Targeting the MEK signaling pathway in non-small cell lung cancer (NSCLC) patients with RAS aberrations
|
Abdel-Rahman, Omar
|
|
2016
|
|
3 |
p. 265-274
|
artikel
|
| 47 |
The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease
|
Berim, Ilya
|
|
2011
|
|
3 |
p. 207-216
|
artikel
|
| 48 |
The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer
|
Pender, Alexandra
|
|
2015
|
|
3 |
p. 97-104
|
artikel
|
| 49 |
The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary disease
|
Ngan, David A.
|
|
2009
|
|
3 |
p. 113-129
|
artikel
|
| 50 |
The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension
|
Gessler, Tobias
|
|
2011
|
|
3 |
p. 195-206
|
artikel
|
| 51 |
The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension
|
Steriade, Alexandru
|
|
2014
|
|
3 |
p. 84-92
|
artikel
|
| 52 |
The role of immunotherapy in the management of childhood asthma
|
Hedlin, Gunilla
|
|
2012
|
|
3 |
p. 137-146
|
artikel
|
| 53 |
The role of monoclonal antibodies in the treatment of severe asthma
|
Tourangeau, Louanne M.
|
|
2011
|
|
3 |
p. 183-194
|
artikel
|
| 54 |
Treatment response according to small airway phenotypes: a real-life observational study
|
Marth, Katharina
|
|
2016
|
|
3 |
p. 200-210
|
artikel
|
| 55 |
Tuberculosis in childhood
|
Shingadia, Delane
|
|
2012
|
|
3 |
p. 161-171
|
artikel
|
Tijdschrift beschrijving